Literature DB >> 24560894

Effects of airway surface liquid pH on host defense in cystic fibrosis.

Abigail R Berkebile1, Paul B McCray2.   

Abstract

Cystic fibrosis is a lethal genetic disorder characterized by viscous mucus and bacterial colonization of the airways. Airway surface liquid represents a first line of pulmonary defense. Studies in humans and animal models of cystic fibrosis indicate that the pH of airway surface liquid is reduced in the absence of cystic fibrosis transmembrane conductance regulator function. Many aspects of the innate host defense system of the airways are pH sensitive, including antimicrobial peptide/protein activity, the rheological properties of secreted mucins, mucociliary clearance, and the activity of proteases. This review will focus on how changes in airway surface liquid pH may contribute to the host defense defect in cystic fibrosis soon after birth. Understanding how changes in pH impact mucosal immunity may lead to new therapies that can modify the airway surface liquid environment, improve airway defenses, and alter the disease course.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  ASL; Airway surface liquid; Antimicrobials; Cystic fibrosis

Mesh:

Substances:

Year:  2014        PMID: 24560894      PMCID: PMC4404156          DOI: 10.1016/j.biocel.2014.02.009

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  54 in total

Review 1.  Mechanisms of acid and base secretion by the airway epithelium.

Authors:  Horst Fischer; Jonathan H Widdicombe
Journal:  J Membr Biol       Date:  2006-11-07       Impact factor: 1.843

2.  Characterization of wild-type and deltaF508 cystic fibrosis transmembrane regulator in human respiratory epithelia.

Authors:  Silvia M Kreda; Marcus Mall; April Mengos; Lori Rochelle; James Yankaskas; John R Riordan; Richard C Boucher
Journal:  Mol Biol Cell       Date:  2005-02-16       Impact factor: 4.138

3.  Release of the antimicrobial peptide LL-37 from DNA/F-actin bundles in cystic fibrosis sputum.

Authors:  R Bucki; F J Byfield; P A Janmey
Journal:  Eur Respir J       Date:  2007-01-10       Impact factor: 16.671

4.  The antimicrobial peptide cathelicidin interacts with airway mucus.

Authors:  Kerstin Felgentreff; Christoph Beisswenger; Matthias Griese; Tanja Gulder; Gerhard Bringmann; Robert Bals
Journal:  Peptides       Date:  2006-09-11       Impact factor: 3.750

5.  Exhaled breath condensate pH measurement in children with asthma, allergic rhinitis and atopic dermatitis.

Authors:  Luigia Brunetti; Ruggiero Francavilla; Riccardina Tesse; Antonella Strippoli; Lorenzo Polimeno; Antonietta Loforese; Vito L Miniello; Lucio Armenio
Journal:  Pediatr Allergy Immunol       Date:  2006-09       Impact factor: 6.377

6.  CFTR regulates phagosome acidification in macrophages and alters bactericidal activity.

Authors:  Anke Di; Mary E Brown; Ludmila V Deriy; Chunying Li; Frances L Szeto; Yimei Chen; Ping Huang; Jiankun Tong; Anjaparavanda P Naren; Vytautas Bindokas; H Clive Palfrey; Deborah J Nelson
Journal:  Nat Cell Biol       Date:  2006-08-20       Impact factor: 28.824

7.  Inactivation of human beta-defensins 2 and 3 by elastolytic cathepsins.

Authors:  Clifford C Taggart; Catherine M Greene; Stephen G Smith; Rodney L Levine; Paul B McCray; Shane O'Neill; Noel G McElvaney
Journal:  J Immunol       Date:  2003-07-15       Impact factor: 5.422

8.  Airway surface pH in subjects with cystic fibrosis.

Authors:  D McShane; J C Davies; M G Davies; A Bush; D M Geddes; E W F W Alton
Journal:  Eur Respir J       Date:  2003-01       Impact factor: 16.671

9.  Abnormal surface liquid pH regulation by cultured cystic fibrosis bronchial epithelium.

Authors:  Raymond D Coakley; Barbara R Grubb; Anthony M Paradiso; John T Gatzy; Larry G Johnson; Sylvia M Kreda; Wanda K O'Neal; Richard C Boucher
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-10       Impact factor: 11.205

10.  Surfactant proteins A and D inhibit the growth of Gram-negative bacteria by increasing membrane permeability.

Authors:  Huixing Wu; Alexander Kuzmenko; Sijue Wan; Lyndsay Schaffer; Alison Weiss; James H Fisher; Kwang Sik Kim; Francis X McCormack
Journal:  J Clin Invest       Date:  2003-05       Impact factor: 14.808

View more
  15 in total

1.  Differential In Vitro and In Vivo Toxicities of Antimicrobial Peptide Prodrugs for Potential Use in Cystic Fibrosis.

Authors:  Éanna Forde; André Schütte; Emer Reeves; Catherine Greene; Hilary Humphreys; Marcus Mall; Deirdre Fitzgerald-Hughes; Marc Devocelle
Journal:  Antimicrob Agents Chemother       Date:  2016-04-22       Impact factor: 5.191

2.  CrossTalk proposal: mucosal acidification drives early progressive lung disease in cystic fibrosis.

Authors:  Miriam F Figueira; Megan J Webster; Robert Tarran
Journal:  J Physiol       Date:  2018-07-17       Impact factor: 5.182

3.  Exposure of Pseudomonas aeruginosa to bactericidal hypochlorous acid during neutrophil phagocytosis is compromised in cystic fibrosis.

Authors:  Nina Dickerhof; Vivienne Isles; Philip Pattemore; Mark B Hampton; Anthony J Kettle
Journal:  J Biol Chem       Date:  2019-07-24       Impact factor: 5.157

Review 4.  Influenza Hemagglutinin Protein Stability, Activation, and Pandemic Risk.

Authors:  Charles J Russell; Meng Hu; Faten A Okda
Journal:  Trends Microbiol       Date:  2018-04-19       Impact factor: 17.079

5.  Interplay between host-microbe and microbe-microbe interactions in cystic fibrosis.

Authors:  Catherine R Armbruster; Tom Coenye; Lhousseine Touqui; Jennifer M Bomberger
Journal:  J Cyst Fibros       Date:  2019-11-02       Impact factor: 5.482

Review 6.  The innate immune function of airway epithelial cells in inflammatory lung disease.

Authors:  Pieter S Hiemstra; Paul B McCray; Robert Bals
Journal:  Eur Respir J       Date:  2015-02-19       Impact factor: 16.671

7.  Acidosis exacerbates in vivo IL-1-dependent inflammatory responses and neutrophil recruitment during pulmonary Pseudomonas aeruginosa infection.

Authors:  Iviana M Torres; Yash R Patankar; Brent Berwin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-10-06       Impact factor: 5.464

Review 8.  pH Dependent Antimicrobial Peptides and Proteins, Their Mechanisms of Action and Potential as Therapeutic Agents.

Authors:  Erum Malik; Sarah R Dennison; Frederick Harris; David A Phoenix
Journal:  Pharmaceuticals (Basel)       Date:  2016-11-01

Review 9.  Role of Soluble Innate Effector Molecules in Pulmonary Defense against Fungal Pathogens.

Authors:  Soledad R Ordonez; Edwin J A Veldhuizen; Martin van Eijk; Henk P Haagsman
Journal:  Front Microbiol       Date:  2017-10-31       Impact factor: 5.640

Review 10.  NETs and CF Lung Disease: Current Status and Future Prospects.

Authors:  Robert D Gray; Brian N McCullagh; Paul B McCray
Journal:  Antibiotics (Basel)       Date:  2015-01-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.